Abstract:Cellular adhesion molecules of the cadherin, integrin, and immunoglobulin superfamilies are important to both growth and metastasis of many cancers, including malignant melanoma. Malignant melanoma is an excellent model for studying these molecules, due in part to a sequential series of five defineable stages. As the malignant phenotype of melanoma cells changes from the noninvasive radial growth phase to the vertical growth phase, which has high metastatic potential, so does the repertoire of the cellular adhesion molecules expressed on the cells surface. The cellular adhesion molecule MCAM/MUC18 confers metastatic potential and increased tumorigenicity to melanoma cells. MCAM/MUC18 mediates homotypic and heterotypic adhesion between melanoma cells and endothelial cells, respectively. Both types of interaction may promote metastasis at different stages in the metastasis cascade. We developed a fully humanized antibody to MCAM/MUC18 (ABX-MA1) that blocked melanoma metastasis in vivo. Furthermore, ABX-MA1 blocked the homotypic interaction between melanoma cells and endothelial cells as well as the promoter and collagenase activity of MMP-2. During melanoma progression the loss of E-cadherin expression disrupts normal homeostasis in the skin by freeing melanoma cells from structural and functional regulation by keratinocytes. The loss of functional E-cadherin is parallelled by a gain in N-cadherin function that mediates homotypic interaction between melanoma cells, facilitates gap-junctional formation with fibroblasts and endothelial cells and promotes melanoma cell migration and survival. In addition, loss of E-cadherin may affect the beta-catenin/wnt signaling pathways, resulting in deregulation of genes involved in growth and metastasis. The integrin family member alpha(v)beta(3) is widely expressed on melanoma cells in the vertical growth phase. When alpha(v)beta(3) is expressed in melanoma cells in the radial growth phase, this integrin is associated with increased tumor growth in vivo. alpha(v)beta(3) may also promote melanoma invasion, through an interaction with MMP-2, and transendothelial migration, via a heterotypic melanomaendothelial cell interaction. This review summarizes recent knowledge on how changes in these adhesion molecules contribute to the acquisition of the metastatic phenotype in human melanoma.

Analysis of Integrin-Dependent Melanoblast Migration During Development

Migration of Hindbrain Neural Crest Cells in the Mouse

Live Imaging of the Dynamics of Mammalian Neural Crest Cell Migration

Multiscale mechanisms of cell migration during development: theory and experiment

Glycan Epitope and Integrin Expression Dynamics Characterize Neural Crest Epithelial-to-Mesenchymal Transition (EMT) in Human Pluripotent Stem Cell Differentiation

Integrating chemical and mechanical signals in neural crest cell migration

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype

Wnt and BMP signaling govern lineage segregation of melanocytes in the avian embryo

Developmentally regulated expression of integrin alpha-6 distinguishes neural crest derivatives in the skin

The melanocyte lineage in development and disease

Identification of Neural Crest and Neural Crest-Derived Cancer Cell Invasion and Migration Genes Using High-throughput Screening and Deep Attention Networks

Induction of the Neural Crest and the Opportunities of Life on the Edge

Analysis of Early Human Neural Crest Development

Cellular Adhesion Pathways and Metastatic Potential of Human Melanoma

Identification and characterization of intermediate states in mammalian neural crest cell epithelial to mesenchymal transition and delamination

Cell Proliferation Drives Neural Crest Cell Invasion of the Intestine.

Cell extrusion - a novel mechanism driving neural crest cell delamination

A new role of the membrane-type matrix metalloproteinase 16 (MMP16/MT3-MMP) in neural crest cell migration

Neural crest lineage analysis: from past to future trajectory

A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation